Review Note
Last Update: 01/29/2025 03:22 AM
Current Deck: ACG Part 2::Cardiac SSU
PublishedCurrently Published Content
Front
SS_CS 1.17 Outline the issues related to the care of patients undergoing cardiopulmonary bypass, including:
• Use of antifibrinolytics
Back
- Standard of care; reduce blood product use
- Block lysine binding sites on plasminogen → prevent interaction with plasmin and fibrin → slowed clot lysis
- Dose 1.5-2g TXA (bolus vs infusion)
No published tags.
Pending Suggestions
No pending suggestions for this note.